Ataraxa LP — Form D
Ataraxa LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-01-30. $1.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-01-30
- Form: D
- Accession: 0001562555-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $1.0M
- Minimum investment: $10K
- Investors: 8
- Date of first sale: 2025-01-15
- Security types: fund interests
- SEC file number: 021-536778
Issuer
- Name: Ataraxa LP
- CIK: 0002053057
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 817 BROADWAY, NEW YORK, NY, 10003
- Phone: 347-614-2682
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| n/a Ataraxa GP LLC | Executive Officer | New York, NY |
| n/a Avenir Management Company, LLC | Executive Officer | New York, NY |
| James Reynolds IV | Promoter | New York, NY |
| Andrew Sugrue | Promoter | NEW YORK, NY |
More